PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing ...
Palisade extended its winning streak to a fourth straight day on Wednesday, jumping 5.26 percent to close at $2.20 apiece as ...
PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and ...
TipRanks on MSN
Palisade Bio granted Japanese patent covering PALI-2108
Palisade Bio (PALI) announced that the Japan Patent Office has granted a key patent covering PALI-2108, the Company’s lead, ...
NUUANU (KHNL) -- We've all heard of those chilling tales of Hawaiian folklore. And two very specific ones always seemed to make the hair on the back of my neck stand, whenever I heard them. One, was ...
Fintel reports that on December 30, 2025, Clear Street initiated coverage of Palisade Bio (NasdaqCM:PALI) with a Buy recommendation. Analyst Price Forecast Suggests 405.31% Upside As of December 21, ...
Staffers at the Tideline, the student newspaper at Palisades Charter High School, are learning about journalism — and life — as they report on the aftermath of the wildfire. Their newsroom was ...
Community members hit the golf course Sunday morning for the “Raise Pali” golf tournament, which supported wildfire recovery efforts for Palisades Charter High School. Around 40% of Pali High’s campus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback